Register Interest

Captix Biomedical Pty Ltd 

Captixbio is a pioneering Australian company developing innovative medical technologies to optimise the therapeutic impact of cell therapies. Captixbio’s IMITATM device is an immuno-protective cell encapsulation technology intended to transform the current cell therapy paradigm for treatment of Type 1 diabetes.  Captixbio is dedicated to transforming the lives of millions of people globally, who currently live with Type 1 diabetes.